TABNAK, Jun. 28 -An Iranian knowledge-based cell therapy product developed from umbilical cord–derived stem cells has entered clinical practice after receiving authorization from the country's Food and Drug Administration (FDA) for the treatment of osteoarthritis, marking another step in the expansion of regenerative medicine technologies in Iran.
News ID: 7529 Publish Date : 2026/06/28
TABNAK, Nov. 18 - The CEO of Royan Stem Cells Company has stressed that despite widespread sanctions and infrastructure challenges, Iran ranked second in the world in the global classification of umbilical cord blood stem cell storage.
News ID: 6943 Publish Date : 2025/11/18